Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
By J. Dalmau, A. Gleichman, Ethan G. Hughes, J. E. Rossi, Xiaoyu Peng, Meizan Lai, S. Dessain, M. Rosenfeld, R. Balice-Gordon, D. Lynch. Lancet Neurology, 2008
2,972 citations recorded by the source corpus.
Summary Background A severe form of encephalitis associated with antibodies against NR1–NR2 heteromers of the NMDA receptor was recently identified. We aimed to analyse the clinical and immunological features of patients with the disorder and examine the effects of antibodies against NMDA receptors in neuronal cultures. Methods We describe the clinical characteristics of 100 patients with encephalitis and NR1–NR2 antibodies. HEK293 cells ectopically expressing single or assembled NR1–NR2 subunits were used to determine the epitope targeted by the antibodies. Antibody titres were measured with ELISA. The effect of antibodies on neuronal cultures was determined by quantitative analysis of NMDA-receptor clusters. Findings Median age of patients was 23 years (range 5–76 years); 91 were women. All patients presented with psychiatric symptoms or memory problems; 76 had seizures, 88 unresponsiveness (decreased conciousness), 86 dyskinesias, 69 autonomic instability, and 66 hypoventilation. 58 (59%) of 98 patients for whom results of oncological assessments were available had tumours, most commonly ovarian teratoma. Patients who received early tumour treatment (usually with immunotherapy) had better outcome (p=0.004) and fewer neurological relapses (p=0.009) than the rest of the patients. 75 patients recovered or had mild deficits and 25 had severe deficits or died. Improvement was associated with a decrease of serum antibody titres. The main epitope targeted by the antibodies is in the extracellular N-terminal domain of the NR1 subunit. Patients’ antibodies decreased the numbers of cell-surface NMDA receptors and NMDA-receptor clusters in postsynaptic dendrites, an effect that could be reversed by antibody removal. Interpretation A well-defined set of clinical characteristics are associated with anti-NMDA-receptor encephalitis. The pathogenesis of the disorder seems to be mediated by antibodies.
Subfields: Biological Psychiatry, Neurology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/dd855374110d7c7789974ad4472f335d53b94cd9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Neurology
In Psychiatry and Mental health
Citations in the corpus
- The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. (2012, positive): “This is also important because relapses occur in 25% of patients and predominantly affect those without tumors or who are suboptimally treated with immunotherapy [6, 7, 14].”
- AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location (2009, neutral): “For example, none of the patients of this study had an ovarian teratoma or experienced development of dyskinesias, autonomic instability, and hypoventilation, which are common features of anti–NMDA receptor encephalitis.(6,14) Neuronal plasticity can be studied through a series of models termed long”
- Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis (2010, methodology): “In two series comprising 181 cases (Dalmau et al., 2008; Florance et al., 2009), there was a strong female predominance (ratio, 8.5: 1.5) and the median age of the patients was 19 years (23 months to 75 years; 40% children).”
- Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. (2013, background): “Affected individuals typically develop prominent psychiatric symptoms, cognitive dysfunction, seizures, orofacial dyskinesias, and autonomic instability [52, 53].”
- Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. (2012, background): “…potassium channel (VGKC) complex antibody encephalitis (Irani et al., 2010a), N-methyl-D-aspartate receptor (NMDAR) antibody encephalitis (Dalmau et al., 2008) or the most recent -amino-3- hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor (Lai et al., 2009) or gamma aminobutyric…”